Tailored Health Literacy Follow-up in Cancer
1 other identifier
interventional
150
1 country
1
Brief Summary
Health literacy refers to personal and relational factors affecting a persons ability to aquire, understand and use health information and health services. In a need assessment study, it was found that there is a need to focus on health literacy factors in the follow-up of people with cancer in the health care services. Thus, this project evaluate the effect of a health literacy intervention in cancer. The intervention provides patients with nurse-led tailored follow-up by phone/digital/personal meetings that addresses their individual HL needs, particularly those needs that impact their quality of life, symptom burden, self-management, and health economic costs. Our main goal is to improve the patients' health literacy, with secondary goals of improving their quality of life, symptom burden, and self-management, and reducing their health care costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Mar 2023
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2022
CompletedFirst Posted
Study publicly available on registry
November 25, 2022
CompletedStudy Start
First participant enrolled
March 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedApril 3, 2023
March 1, 2023
1.8 years
November 10, 2022
March 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
General Health literacy measured with the Health Literacy Questionnaire (HLQ)
Change of Health Literacy questionnaire
6 months, 9 months
Secondary Outcomes (8)
Electronic Health Literacy measured with the electronic Health Literacy Questionnaire (eHLQ)
6 months, 9 months
General symptoms measured with the Edmonton Symptom Assessment System (ESAS)
6 months, 9 months
Oral symptoms measured with four items selected from the European Organization for REsearch and Treatment of Cancer-oral health 15 (EORTC-OH 15)
6 months, 9 months
Self-management measured with the Health Education Impact Questionnaire (HeiQ)
6 months, 9 months
Self-Efficacy measured with the General Self-efficacy Scale (GSE)
6 months, 9 months
- +3 more secondary outcomes
Study Arms (2)
The Intervention Group
EXPERIMENTALThe intervention group will receive a tailored intervention based on each individuals health literacy needs. A project nurse with broad experience in cancer care will be trained in Motivational Interviewing techniques to provide follow-up for the patients in the intervention group in a period of 9 months.
Usual care group
NO INTERVENTIONUsual care group will receive usual follow-up.
Interventions
1. Participants are invited to a consultation with the project nurse where the project nurse will use baseline data to identify the patient's HL needs, QOL, symptom burden and issues related to self-management of their cancer and treatment. These data will be used together with an interview questionnaire specifically developed to communicate HL needs (i.e. CHAT), which form the basis for the individualized HL support. 2. Actions: Based on results of the consultation, the project nurse and the patient will use a worksheet of possible actions to identify those most relevant to the patient's individual needs. Based on this, different self-management tasks and actions will be offered, and an individual tailored follow-up plan will be made. The patient and the project nurse will use a workbook containing information on the follow-up plan that will be added into medical record. 3. Telephone/digital conversations with the project every second month for a period of 9 months.
Eligibility Criteria
You may qualify if:
- Diagnosed with cancer
- Above 18 years old
- Receiving treatment at the main intervention hospital
You may not qualify if:
- Not diagnosed with cancer
- Not above 18 years old
- Not in treatment at the intervention hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lovisenberg Diakonale Hospitallead
- University of Oslocollaborator
Study Sites (1)
Lovisenberg Diakonale Hospital
Oslo, 0440, Norway
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Christine R Borge, PhD
Lovisenberg Diaconal Hospital and University of Oslo
- STUDY CHAIR
Astrid K Wahl, PhD
University of Oslo
- STUDY CHAIR
Simen A Steindal, PhD
VID
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The main researcher and PhD candidate will be blinded to the randomizing procedure. However, in this project, it is not feasible to blind the participants, HCPs or PhD candidate to the participants' group. The participants will be randomized right after the first assessment.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
November 10, 2022
First Posted
November 25, 2022
Study Start
March 30, 2023
Primary Completion
December 31, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
April 3, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share